FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1292211000001101: Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21450101000001119 Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21450201000001114 Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Is pack of Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops false Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has active ingredient Xylometazoline hydrochloride false Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has active ingredient Antazoline sulfate false Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has manufactured dose form Drops dose form false Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has VMP Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has specific active ingredient Xylometazoline hydrochloride true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has specific active ingredient Antazoline sulfate true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has dispensed dose form Drops dose form false Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has dispensed dose form Conventional release eye drops true Inferred relationship Existential restriction modifier
Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Has unit of administration drop false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Otrivine Antistin 0.5%/0.05% eye drops (Novartis Consumer Health UK Ltd) 10 ml Is a True Antazoline 0.5% / Xylometazoline 0.05% eye drops 10 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start